VIKING THERAPEUTICS, INC. (VKTX) Operating cash flow 2016–2025
VIKING THERAPEUTICS, INC. (VKTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$278.7MFY2025 · since FY2016: -$11.1M → -$278.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$278.7M | -217.4% |
| FY2024 | -$87.8M | -19.6% |
| FY2023 | -$73.4M | -51.6% |
| FY2022 | -$48.4M | -1.7% |
| FY2021 | -$47.6M | -118.5% |
| FY2020 | -$21.8M | +12.0% |
| FY2019 | -$24.8M | -32.0% |
| FY2018 | -$18.8M | -27.1% |
| FY2017 | -$14.8M | -33.3% |
| FY2016 | -$11.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VKTX financial trends
VKTX RevenueVKTX Net incomeVKTX Net marginVKTX Gross profitVKTX Gross marginVKTX Operating incomeVKTX Operating marginVKTX Free cash flowVKTX Capital expendituresVKTX Return on equityVKTX Stock buybacksVKTX Dividends paidVKTX Total assetsVKTX Total liabilitiesVKTX Shareholders’ equityVKTX overview →